A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study ...

Cancer advocates, researchers, clinicians and patients are speaking out in a new STAT News article published this week about ...

A promising treatment to extend the lives of glioblastoma patients is waiting on the worst form of bureaucracy ...

Every day, 160 breast cancer patients will get free of charge treatment on state-of-the-art Helix Tomotherapy units,” ...

Anixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine. Anixa Biosciences, Inc. March 24, 2025.

AUDREY’S CHILDREN tells the incredible true story of Dr. Audrey Evans, a pediatric oncologist who worked tirelessly to ...

At a time when Ohio is facing an ongoing health crisis, Gov. Mike DeWine has chosen ideology over public health, ...

HHS PULLS THE PLUG — The Trump administration is closing HHS’ long Covid office, according to an internal email seen by ...

When President Donald Trump canceled $400 million in funding to Columbia University over its handling of student protests ...

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, today ...

The developer of a spray-based erectile dysfunctional treatment, LTR Pharma has found a pre-approval route to the US market.

Opinion: Arnold & Porter's Mehrin "Mir" Masud-Elias questions the National Institute of Health's indirect cost cap, saying ...